Midday Movers: Banks Slide, Biotech Pops, Chips Catch a Bid

Paul Jackson

January 13, 2026

Key Points

  • Banks fell on weaker investment banking revenue and regulatory uncertainty.

  • Biotech and healthcare names rallied on upbeat guidance and earnings updates.

  • Semiconductors surged after bullish analyst upgrades tied to data center demand.

  • Aerospace and defense stocks climbed on orders, partnerships, and capacity expansion.

Stocks Making the Biggest Moves Midday

Midday trading was a split screen: banks sold off, healthcare caught bids, and semiconductors rallied as the market leaned back into the “AI infrastructure” theme.

Financials: JPMorgan Slides

JPMorgan dropped more than 3% after investment banking fees came in lighter than expected. The stock also caught extra heat as rate-cap chatter around credit cards resurfaced, a headline that tends to hit lenders fast because it directly pressures profitability.

Restaurants: Chipotle Falls

Chipotle sank more than 3% after reaffirming 2025 guidance that still points to a low single-digit decline in comparable sales. The company also announced an interim CMO, and markets typically treat marketing leadership changes cautiously when traffic is already under scrutiny.

Healthcare: Moderna Pops, Cardinal Gains

Moderna jumped more than 14% after management projected roughly $1.9B in 2025 sales, above the midpoint of earlier guidance. Cardinal Health rose nearly 4% after lifting full-year guidance, while Option Care Health spiked about 10% on preliminary results, early 2026 outlook, and an expanded buyback authorization.

Industrials: Boeing Rebounds

Boeing climbed more than 3% after reporting a strong finish to 2025 orders — including a big December tally — and regaining the lead over Airbus on annual orders for the first time in years. Investors are still watching execution, but order momentum is a clean catalyst.

Semiconductors: Intel and AMD Rip

Intel surged nearly 8% and AMD gained around 6% after KeyBanc upgraded both to overweight, pointing to upside tied to a potential memory-cycle tailwind and outsized data center demand — the same “compute buildout” engine that keeps pulling money back into chips.

Other Notable Movers

Delta slid more than 3% after mixed quarterly results. Travere Therapeutics cratered over 30% after additional FDA information requests raised new uncertainty around a kidney drug filing.

WSA Take

Midday action shows investors rotating aggressively between sectors — trimming banks on regulatory risk, chasing biotech clarity, and leaning back into semiconductors as data center demand regains momentum. Volatility remains selective, not systemic.

Read our recent coverage on Copper Becoming a Critical Asset in 2026.

Explore more market insights on the WallStreetAccess homepage.


Disclaimer

WallStAccess does not work with or receive compensation from any companies mentioned. This content is for informational and educational purposes only and should not be considered financial advice. Always conduct independent research before investing.

Author

Paul Jackson

RELATED ARTICLES

Subscribe